SAR-439459 is a human monoclonal antibody (mAb) targeting TGFB1/TGFbeta-1. It blocks TGFbeta-mediated pSMAD signaling and inhibits T cell and NK cell activity. Additionally, SAR-439459 exhibits antitumor properties.
Target:
TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted